Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1619061

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1619061

Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Service (Sample Preparation, Sequencing and Library Preparation), By Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL)), By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Microbiome Sequencing Services Market size was valued at USD 1.37 billion in 2022 and is poised to grow from USD 1.52 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).

The market for microbiome sequencing services is experiencing rapid growth driven by advancements in genetic technology, increased awareness of the human microbiome's role in health, and a rising demand for personalized medicine. Research highlighting the relationship between microbial communities and overall health fuels consumer interest in understanding their own microbiomes, thus elevating the need for sequencing services. These services are becoming integral in medical treatments, with microbiome-based medications for various diseases emerging. The popularity of multi-omics approaches-combining transcriptomics, metabolomics, and genomic data-enhances research outcomes, reinforcing the intricate connection between bacteria and human health. Additionally, advancements in bioinformatics are needed to process growing microbial genomic data, paving the way for accurate diagnoses and enhancing applications in environmental studies and agriculture.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbiome Sequencing Services Market Segmental Analysis

Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbiome Sequencing Services Market

The global microbiome sequencing services market is significantly driven by the rising demand for personalized medicine. As healthcare increasingly shifts towards tailored approaches for individuals, microbiome analysis becomes essential in understanding the unique composition of microorganisms within each patient. This targeted analysis aids in the accurate diagnosis and effective management of various health conditions, enhancing treatment outcomes. Consequently, the growing emphasis on personalized healthcare solutions is fueling the expansion of the microbiome sequencing services market, as more healthcare professionals seek to incorporate these advanced analytical techniques into their practices to optimize patient care.

Restraints in the Global Microbiome Sequencing Services Market

A major constraint facing the Global Microbiome Sequencing Services market is the prohibitive cost associated with sequencing. Despite advancements in technology, the expenses related to sequencing equipment, reagents, and data analysis remain substantial. This financial barrier poses challenges for smaller research institutions and clinics, making it difficult for them to access and implement these services. As a result, the high costs hinder widespread adoption and utilization of microbiome sequencing, ultimately stifling the growth prospects of the market and limiting opportunities for innovation and research in the field.

Market Trends of the Global Microbiome Sequencing Services Market

The global microbiome sequencing services market is experiencing a significant trend toward the integration of Artificial Intelligence (AI) and machine learning technologies. This shift enhances the analysis of complex microbiome data, facilitating a deeper understanding of microbial interactions and their implications for health and disease prevention. As AI-driven tools become more prevalent, they enable researchers and healthcare professionals to derive actionable insights from vast amounts of sequencing data, leading to improved therapeutic strategies and personalized medicine approaches. Consequently, the demand for advanced microbiome analysis services is anticipated to surge, reflecting a broader movement towards data-driven solutions in life sciences and healthcare sectors.

Product Code: SQMIG35J2091

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Microbiome Sequencing Services Market Size by Service & CAGR (2024-2031)

  • Market Overview
  • Sample Preparation
  • Sequencing and Library Preparation
  • Data Analysis

Global Microbiome Sequencing Services Market Size by Technology & CAGR (2024-2031)

  • Market Overview
  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Others

Global Microbiome Sequencing Services Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Others

Global Microbiome Sequencing Services Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Clinics
  • Others

Global Microbiome Sequencing Services Market Size & CAGR (2024-2031)

  • North America, (Service, Technology, Application, End User)
    • US
    • Canada
  • Europe, (Service, Technology, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Service, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Service, Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Service, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microbiome Insights Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR DNA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baseclear BV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinical Microbiomics AS
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rancho Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metabiomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CosmosID
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZIFO
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Realbio Technology (RBT) Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Second Genome
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!